Sexual health drugs firm Fast Track Pharma seeking to raise 2m in AIM float

By Daily Mail City & Finance

|

A pharmaceutical company that specialises in developing drugs by putting together existing treatments is to float on the Alternative Investment Market.

Fast Track Pharma is seeking to raise 2million, which will allow it to increase the number of products it develops. The listing will give it a market value of 10million.

The firm, which focuses on sexual health and has developed a treatment for erectile dysfunction, says the time taken to test new drugs is greatly reduced by using others that already have licences.

Sexual health focus: Fast Track has developed a treatment for erectile dysfunction

Sexual health focus: Fast Track has developed a treatment for erectile dysfunction

Executive chairman Dr Steven Powell said: ‘The funds raised will help to support . . . future opportunities.’

The comments below have not been moderated.

The will find stiff competition in this business field

0
1
Click to rate

The views expressed in the contents above are those of our users and do not necessarily reflect the views of MailOnline.

By posting your comment you agree to our house rules.

Who is this week's top commenter? Find out now